233 related articles for article (PubMed ID: 23782174)
1. Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia.
Zhang Z; Gao Y; Zhang L; Jia L; Wang P; Zhang L; Li H
Hypertens Pregnancy; 2013 Aug; 32(3):270-80. PubMed ID: 23782174
[TBL] [Abstract][Full Text] [Related]
2. Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia.
Zhao S; Gu Y; Dong Q; Fan R; Wang Y
Placenta; 2008 Dec; 29(12):1024-8. PubMed ID: 18986700
[TBL] [Abstract][Full Text] [Related]
3. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
[TBL] [Abstract][Full Text] [Related]
4. Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.
Wang Y; Lewis DF; Gu Y; Zhao S; Groome LJ
Hypertension; 2011 Feb; 57(2):336-42. PubMed ID: 21173340
[TBL] [Abstract][Full Text] [Related]
5. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
Li Y; Wang Y; Qi L
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
[TBL] [Abstract][Full Text] [Related]
6. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
8. Comparison of interleukin-6 levels in maternal and umbilical cord blood in early- and late-onset preeclampsia.
Küçük M; Sezer SD; Yenisey Ç; Yüksel H; Odabaşı AR
Gynecol Endocrinol; 2012 Aug; 28(8):640-3. PubMed ID: 22296277
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy.
Chen H; Zhang X; Liao N; Wen F
Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232
[TBL] [Abstract][Full Text] [Related]
10. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
Weiss TW; Arnesen H; Seljeflot I
Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
[TBL] [Abstract][Full Text] [Related]
11. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
[TBL] [Abstract][Full Text] [Related]
13. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS
J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
16. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.
Robinson M; Gray SR; Watson MS; Kennedy G; Hill A; Belch JJ; Nimmo MA
Scand J Med Sci Sports; 2010 Apr; 20(2):282-90. PubMed ID: 19422646
[TBL] [Abstract][Full Text] [Related]
17. [Expression changes and clinical significance of annexin V in maternal blood and placenta in patients with preeclampsia].
Xin H; Wang HL
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):88-93. PubMed ID: 21426764
[TBL] [Abstract][Full Text] [Related]
18. [Relationships between concentrations of free fatty acid in serum and oxidative-damage levels in placental mitochondria and preeclampsia].
Yan JY; Xu X
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):412-7. PubMed ID: 22932105
[TBL] [Abstract][Full Text] [Related]
19. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
[TBL] [Abstract][Full Text] [Related]
20. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]